Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,447,712
+$1,157,065 QoQ
Shares Held
1,207
+282.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,805
of 4,605 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. LLY ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,447,712 | 1,207 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $290,647 | 316 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,231,583 | 1,146 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $48,832 | 64 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $49,889 | 64 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $52,858 | 64 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $54,040 | 70 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $58,472 | 66 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $53,417 | 59 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $45,899 | 59 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $34,392 | 59 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $27,393 | 51 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $21,104 | 45 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $23,695 | 69 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $16,462 | 45 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $14,550 | 45 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,484 | 20 | Shares | Sole | 2022-07-25 | |
| 2021-12-31 | $5,248 | 19 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,389 | 19 | Shares | Sole | 2021-10-20 | |
| 2021-03-31 | $24,286 | 130 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $21,949 | 130 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $19,242 | 130 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $21,343 | 130 | Shares | Sole | 2020-07-14 | |
| No filing history on record for this holder in this stock. | ||||||